Seeking Alpha

  Keryx Biopharmaceuticals, Inc. (KERX) - NASDAQ

  • RD Gupta | Send Message 11 Jun 2011

    Still think KERX is undervalued, Could be a double in 12 mths. Waiting to see what groupon does. Great article at
      KERX vs. ETF Alternatives
      Company Description
      Keryx Biopharmaceuticals, Inc., is a biopharmaceutical company focused on the acquisition, development and commercialization of pharmaceutical products for the treatment of renal disease. It is developing ZerenexTM an oral, ferric iron-based compound.